Yuchuan Wang

Yuchuan Wang

Auto-generated profile, based on publicly available information

Yuchuan Wang

School of Chemistry, Sun Yat-sen University, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
CFCatherine A. Foss
Catherine A. Foss
RMRonnie C. Mease
Ronnie C. Mease
HFHong Fan
Hong Fan
YWYuchuan Wang
Yuchuan Wang
HRHayden T. Ravert
Hayden T. Ravert
MPMartin G. Pomper
Martin G. Pomper
Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our goal in this study was to develop a series of PSMA-based imaging agents for clinical use. Experimental Design: We have synthesized and evaluated the in vivo biodistribution of two radiolabeled urea derivatives that have high affinity for PSMA in severe combined immunodeficient mice harboring MCF-7 (breast, PSMA-negative), PC-3 (prostate, PSMA-negative), and LNCaP (prostate, PSMA-positive) xenografts. Radiopharmaceutical binding selectivity and tumor uptake were also evaluated in vivo using dedicated small animal positron emission tomography, single photon emission computed tomography, and gamma scintigraphic imaging devices. N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-[11C]methyl-l-cysteine ([11C]DCMC Ki, 3.1 nmol/L) and N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-[125I]iodo-l-tyrosine ([125C]DCIT Ki, 1.5 nmol/L) were synthesized using [11C]CH3I and with [125I]NaI/Iodogen, respectively. Results: At 30 minutes postinjection, [11C]DCMC and [125I]DCIT showed tumor/muscle ratios of 10.8 and 4.7, respectively, with clear delineation of LNCaP-derived tumors on imaging. MCF-7- and PC-3-derived tumors showed significantly less uptake of [11C]DCMC or [125I]DCIT. Conclusion: These results show the feasibility of imaging PSMA-positive prostate cancer using low molecular weight agents.

14 January 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CBChetan Bettegowda
Chetan Bettegowda
CFCatherine A. Foss
Catherine A. Foss
ICIan Cheong
Ian Cheong
YWYuchuan Wang
Yuchuan Wang
LDLuis Diaz
Luis Diaz
MPMartin Pomper
Martin Pomper
Bacterial infections provide diagnostic dilemmas that could be enlightened by modern imaging technologies. We have developed a simple method for imaging bacterial infections in mice that relies on the phosphorylation and trapping of the thymidine kinase (TK) substrate 1-(2′-deoxy-2′-fluoro-β- d -arabinofuranosyl)-5-[ 125 I] iodouracil ([ 125 I]FIAU) within bacteria. FIAU was found to inhibit the growth of WT Escherichia coli but not a TK – strain, indicating that WT E. coli could metabolize this compound. In silico analyses demonstrated that all pathogenic strains of bacteria whose genomes have been sequenced contain a TK gene highly homologous to the E. coli TK. Accordingly, we demonstrated that localized infections caused by representatives of five genera of bacteria could be readily imaged with [ 125 I]FIAU. Such imaging provides a general method for the diagnosis of localized bacterial infections that could be translatable to the clinic.

20 February 2014 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
AHAndrew G. Horti
Andrew G. Horti
YGYongjun Gao
Yongjun Gao
HKHiroto Kuwabara
Hiroto Kuwabara
YWYuchuan Wang
Yuchuan Wang
SASofya Abazyan
Sofya Abazyan
RDRobert F. Dannals
Robert F. Dannals
The α7-nicotinic cholinergic receptor (α7-nAChR) is a key mediator of brain communication and has been implicated in a wide variety of central nervous system disorders. None of the currently available PET radioligands for α7-nAChR are suitable for quantitative PET imaging, mostly because of insufficient specific binding. The goal of this study was to evaluate the potential of 18F-ASEM (18F-JHU82132) as an α7-nAChR radioligand for PET. Methods: The inhibition binding assay and receptor functional properties of ASEM were assessed in vitro. The brain regional distribution of 18F-ASEM in baseline and blockade were evaluated in DISC1 mice (dissection) and baboons (PET). Results: ASEM is an antagonist for the α7-nAChR with high binding affinity (Ki = 0.3 nM). 18F-ASEM readily entered the baboon brain and specifically labeled α7-nAChR. The in vivo specific binding of 18F-ASEM in the brain regions enriched with α7-nAChRs was 80%–90%. SSR180711, an α7-nAChR–selective partial agonist, blocked 18F-ASEM binding in the baboon brain in a dose-dependent manner, suggesting that the binding of 18F-ASEM was mediated by α7-nAChRs and the radioligand was suitable for drug evaluation studies. In the baboon baseline studies, the brain regional volume of distribution (VT) values for 18F-ASEM were 23 (thalamus), 22 (insula), 18 (hippocampus), and 14 (cerebellum), whereas in the binding selectivity (blockade) scan, all regional VT values were reduced to less than 4. The range of regional binding potential values in the baboon brain was from 3.9 to 6.6. In vivo cerebral binding of 18F-ASEM and α7-nAChR expression in mutant DISC1 mice, a rodent model of schizophrenia, was significantly lower than in control animals, which is in agreement with previous postmortem human data. Conclusion: 18F-ASEM holds promise as a radiotracer with suitable imaging properties for quantification of α7-nAChR in the human brain.

Verified
Journal Article
Open access
PDF file
XLXuewen Liu
Xuewen Liu
YWYuchuan Wang
Yuchuan Wang
GCGuangming Chang
Guangming Chang
FWFeng Wang
Feng Wang
FWFei Wang
Fei Wang
XGXin Geng
Xin Geng
The activation of telomerase is one of the key events in the malignant transition of cells, and the expression of human telomerase reverse transcriptase (hTERT) is indispensable in the process of activating telomerase. The pre-mRNA alternative splicing of hTERT at the post-transcriptional level is one of the mechanisms for the regulation of telomerase activity. Shifts in splicing patterns occur in the development, tumorigenesis, and response to diverse stimuli in a tissue-specific and cell type–specific manner. Despite the regulation of telomerase activity, the alternative splicing of hTERT pre-mRNA may play a role in other cellular functions. Modulating the mode of hTERT pre-mRNA splicing is providing a new precept of therapy for cancer and aging-related diseases. This review focuses on the patterns of hTERT pre-mRNA alternative splicing and their biological functions, describes the potential association between the alternative splicing of hTERT pre-mRNA and telomerase activity, and discusses the possible significance of the alternative splicing of the hTERT pre-mRNA in the diagnosis, therapy, and prognosis of cancer and aging-related diseases.

26 February 2015 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
SRSangeeta Ray
Sangeeta Ray
CFCatherine A. Foss
Catherine A. Foss
MPMrudula Pullambhatla
Mrudula Pullambhatla
YWYuchuan Wang
Yuchuan Wang
SSSenthamizhchelvan Srinivasan
Senthamizhchelvan Srinivasan
MPMartin Pomper
Martin Pomper
86Y (half-life = 14.74 h, 33% β+) is within an emerging class of positron-emitting isotopes with relatively long physical half-lives that enables extended imaging of biologic processes. We report the synthesis and evaluation of 3 low-molecular-weight compounds labeled with 86Y for imaging the prostate-specific membrane antigen (PSMA) using PET. Impetus for the study derives from the need to perform dosimetry estimates for the corresponding 90Y-labeled radiotherapeutics. Methods: Multistep syntheses were used in preparing 86Y-4–6. PSMA inhibition constants were evaluated by competitive binding assay. In vivo characterization using tumor-bearing male mice was performed by PET/CT for 86Y-4–6 and by biodistribution studies of 86Y-4 and 86Y-6 out to 24 h after injection. Quantitative whole-body PET scans were recorded to measure the kinetics for 14 organs in a male baboon using 86Y-6. Results: Compounds 86Y-4–6 were obtained in high radiochemical yield and purity, with specific radioactivities of more than 83.92 GBq/μmol. PET imaging and biodistribution studies using PSMA-positive PC-3 PIP and PSMA-negative PC-3 flu tumor-bearing mice revealed that 86Y-4–6 had high site-specific uptake in PSMA-positive PC-3 PIP tumor starting at 20 min after injection and remained high at 24 h. Compound 86Y-6 demonstrated the highest tumor uptake and retention, with 32.17 ± 7.99 and 15.79 ± 6.44 percentage injected dose per gram (%ID/g) at 5 and 24 h, respectively. Low activity concentrations were associated with blood and normal organs, except for the kidneys, a PSMA-expressing tissue. PET imaging in baboons reveals that all organs have a 2-phase (rapid and slow) clearance, with the highest uptake (8 %ID/g) in the kidneys at 25 min. The individual absolute uptake kinetics were used to calculate radiation doses using the OLINDA/EXM software. The highest mean absorbed dose was received by the renal cortex, with 1.9 mGy per MBq of 86Y-6. Conclusion: Compound 86Y-6 is a promising candidate for quantitative PET imaging of PSMA-expressing tumors. Dosimetry calculations indicate promise for future 90Y or other radiometals that could use a similar chelator/scaffold combination for radiopharmaceutical therapy based on the structure of 6.

1 January 2018 in NeuroImage
Verified
Journal Article
Closed access
JCJennifer M. Coughlin
Jennifer M. Coughlin
YDYong Du
Yong Du
HRHailey B. Rosenthal
Hailey B. Rosenthal
SSStephanie Slania
Stephanie Slania
SKSoo Min Koo
Soo Min Koo
MPMartin Pomper
Martin Pomper